Dupixent (dupilumab) is a brand-name injectable drug prescribed for asthma, eczema, and other inflammatory ... When you start Dupixent treatment, you and your doctor will discuss which form ...

The FDA is to review Sanofi/Regeneron's Dupixent as a treatment for asthma, a new use that could more than double its sales following its previous approval for eczema. Analysts predict peak annual ...

A person may be able to treat eczema without steroids. Possible treatment options include topical calcineurin inhibitors, crisaborole, JAK inhibitors, and more. Corticosteroids (steroids ...

Dupixent (dupilumab ... Biologics aren't usually a first-line treatment for eczema. This means that before starting one, your healthcare provider will want you to try other treatment options.

If a child or infant develops symptoms of infected eczema, their parent or caregiver should take them to a doctor immediately. Fungal infections require antifungal creams or medication.

One is Dupixent, an eczema treatment whose rights it shares with Sanofi, based in France. The other is Eylea, a medicine for wet age-related macular degeneration (an eye disease) that it comarkets ...

Of the hundreds of drugs that entered ... approvals. 1. Dupixent (dupilumab) for chronic obstructive pulmonary disease: The monoclonal antibody, already approved for eczema, asthma and long ...

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...